Introduction
So-called tricyclic antidepressants were introduced into clinical practice 20 years ago (Kuhn, 1958) . Since then the number of cases of overdose from these drugs has increased steadily so that today 10 000 patients (or 10% of all overdoses) are admitted each year to hospital in England and Wales for this reason. The relative frequencies of the various clinical features have been described in a number of series (Goel and Shanks, 1974; Brown, Dwyer and Stocks, 1971; Fournier, 1973; Bismuth et al., 1969; Noble and Matthew, 1969;  Thorstrand, 1976; Frejaville et al., 1965 Frejaville et al., , 1966 Sedal et al., 1972; Serafimovski et al., 1975; Biggs et al., 1977; Noto, Robert and Hanote, 1970; Christensen and Andersen, 1977) . Anti-cholinergic effects, pyramidal signs and sinus tachycardia occur commonly but coma, convulsions, respiratory depression, electrocardiographic abnormalities and myocardial depression may all ensue. There has been only one large study of tricyclic antidepressant poisoning in adults in the United Kingdom, by Noble and Matthew (1969 (Proudfoot and Park, 1978 (Pinder et al., 1977 (Broadhead, 1978) . Clearly, if antidepressants are to be prescribed for depression in childhood then parents must be warned of their dangers and must supervise their administration.
Over 40% of the children in this survey could have ingested only trivial amounts of drug for they were reported to have remained symptom free. The incidence of significant toxicity in childhood poisoning as a whole is low, Broadhead reporting that less than one in 10 of children admitted to hospital for poisoning was in fact suffering from an adverse reaction (Broadhead, 1978) . It seems likely that a considerable number of children could have been observed at home and thus spared hospital admission In the case of tricyclic antidepressants it is probably safe to allow a child home if he remains unaffected 6 hr after an alleged overdose. However, if a slowrelease preparation is implicated then a 12-hr observation is desirable.
The authors were unable to show any statistically significant differences between the toxicity of individual antidepressants although overdose of amitriptyline-like drugs resulted in a significantly higher incidence of coma than overdose of imipramine and its analogues (P<O001). This difference may have been because patients taking amitriptyline-like drugs ingest larger quantities than patients taking imipramine-like drugs, or because amitriptyline and its congeners are intrinsically more toxic. Unfortunately the information on the amounts of drug ingested was insufficiently detailed to allow the authors to conclude which of these explanations was correct. In only one of the published series has it been suggested that there were differences between the individual antidepressants. Among 153 patients reported by Thorstrand (1976) , all 4 patients taking dibenzepin died. In the present series only 2 patients took this drug, so that definite conclusions are not possible, although one patient did die. It has also been suggested that doxepin is less cardiotoxic than other drugs because it does not prolong intraventricular conduction (Burrows et al., 1976 ) although a similar incidence was found of cardiotoxicity with this drug compared with the others. Park and Proudfoot (1977) have reported a high incidence of coma and convulsions in maprotiline overdosage and in the present series 25% of the patients taking this drug developed these complications. Recently, there have been reports of convulsions occurring during the therapeutic use of this drug (Shepherd and Kerr, 1978; Hall and Russell, 1978 (12-7%) . Maprotiline is available in 5 tablet strengths ranging from 10 to 150 mg and this made it impossible to determine whether the high incidence of convulsions was due to the patients ingesting excessively large amounts of drug, since it has been suggested that convulsions may result from therapeutic use of high doses of this drug (Burley, Jukes and Steen, 1978; Hall and Russell, 1978; Shepherd and Kerr, 1978) . The authors are unable to say whether maprotiline is intrinsicially more toxic than the other tricyclic antidepressants but their study of this drug is continuing.
The number of patients reported to have received no treatment was higher than expected (357 patients, 73%0). This probably reflects the attitude of doctors who do not regard the supportive care these patients receive as 'treatment'.
In a recent survey of the use of drugs in general practice (Skegg, Doll and Perry, 1977) it was found that in a single year, 11.200 of middle-aged women received antidepressant medication. With this number of prescriptions it is not surprising that overdose is a common problem. The present study shows that it is also a significant clinical problem with a substantial proportion of both adults and children developing serious symptoms such as coma, convulsions, and myocardial depression. It would be prudent for doctors prescribing these drugs to warn patients and relatives of their dangers, to monitor response to treatment at regular intervals and to issue repeat prescriptions only if the drug is still needed and the patient is actually taking it. For someone with suicidal inclinations or with a past history of parasuicide, it may prove wiser to prescribe one of the more recently introduced antidepressants such as mianserin, nomifensine and flupenthixol if further studies confirm the initial reports suggesting that they are less toxic when taken in overdose. Montgomery, Crome and Braithwaite, 1978) .
